Octagon Capital Advisors LP Apellis Pharmaceuticals, Inc. Call Options Transaction History
Octagon Capital Advisors LP
- $433 Million
- Q2 2024
Call Options
2 transactions
Others Institutions Holding APLS
# of Institutions
301Shares Held
114MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$468 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$332 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$317 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$280 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$166 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.14B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...